Clinical trial

Immune Cell Therapy for Advanced Solid Tumors

NCT07260058

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2025-12-01Date precision: day

Registry last updated2025-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer (Locally Advanced or Metastatic)unresolved

Liver Cancer (Locally Advanced or Metastatic)unresolved

Colorectal Cancer (Locally Advanced or Metastatic)unresolved

Breast Cancer (Locally Advanced or Metastatic)unresolved

Advanced Solid Tumorsunresolved

Interventions

Autologous immune CellsBIOLOGICAL

Standard chemotherapyDRUG

Sponsors & collaborators

Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.lead sponsor

Liaoning Cancer Hospital & Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07260058 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.